Show simple item record

dc.creatorChiou, George C. Y.
dc.date.accessioned2019-07-12T20:48:11Z
dc.date.available2019-07-12T20:48:11Z
dc.date.issued1993-03-16
dc.identifier.urihttp://hdl.handle.net/1969.1/177526
dc.description.abstractA novel compound for the treatment and prevention of ocular inflammation is disclosed. The compound, OB-101, is effective at both the early and late phases of inflammation. The compound is useful for the treatment of inflammation in both the anterior and posterior portions of the eye.en
dc.languageeng
dc.publisherUnited States. Patent and Trademark Office
dc.rightsPublic Domain (No copyright - United States)en
dc.rights.urihttp://rightsstatements.org/vocab/NoC-US/1.0/
dc.titleUse of OB-101 to treat ocular inflammationen
dc.typeUtility patenten
dc.format.digitalOriginreformatted digitalen
dc.description.countryUS
dc.contributor.assigneeTexas A&M University System
dc.identifier.patentapplicationnumber07/801891
dc.subject.uspcprimary514/227.2
dc.subject.uspcother424/427
dc.subject.uspcother514/912
dc.date.filed1991-12-03
dc.publisher.digitalTexas A&M University. Libraries


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record